![Soraya Bekkali](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Soraya Bekkali
Directeur/Membre du Conseil chez
Vedere Bio II, Inc.
Profil
Soraya Bekkali is currently a Director at Vedere Bio II, Inc. She was previously the President, Director & Head-R&D at Gyroscope Therapeutics Ltd., the Chief Medical Officer at Fovea Pharmaceuticals SA, and the Chief Medical Officer & Senior Vice President at Lysogene SA. Bekkali received an undergraduate degree from Sorbonne Université.
Postes actifs de Soraya Bekkali
| Sociétés | Poste | Début |
|---|---|---|
Vedere Bio II, Inc.
 Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Develops ocular gene therapy | Directeur/Membre du Conseil | - |
Anciens postes connus de Soraya Bekkali
| Sociétés | Poste | Fin |
|---|---|---|
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | President | 01/07/2019 |
| LYSOGENE | Directeur Technique/Scientifique/R&D | - |
Fovea Pharmaceuticals SA
 Fovea Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for the treatment of ocular diseases | Directeur Technique/Scientifique/R&D | - |
Formation de Soraya Bekkali
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
8
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Fovea Pharmaceuticals SA
Fovea Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for the treatment of ocular diseases | Health Technology |
Sorbonne Université
 Sorbonne Université Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lysogene SA
 Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders | Health Technology |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | Health Technology |
Vedere Bio II, Inc.
Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Develops ocular gene therapy | Commercial Services |
